ICSMA-20-196-01
·
Published 2020-10-20
·
View on CISA ICS-CERT ↗
Capsule Technologies SmartLinx Neuron 2 (Update A)
CVSS 7.6
HIGH
Risk Summary
Successful exploitation of this vulnerability could provide an attacker with full control of a trusted device on a hospital 's internal network.
CVEs (1)
Remediations
- Capsule Technologies recommends the following mitigations:
Affected Vendors
Capsule Technologies
Affected Products (1)
Capsule Technologies
·
Capsule Technologies SmartLinx Neuron 2
<= 9.0.3
Affected Sectors
Healthcare and Public Health
Get alerted to advisories like this
OTWarden monitors CISA, BSI, Siemens, Rockwell and more — and emails you within 2 hours when your vendors are affected.
Start free trial Learn more